secwatch.observer — SEC 8-K summary
======================================

Issuer:     OptimizeRx Corp (OPRX)
CIK:        0001448431
Form:       8-K
Filed at:   2026-03-30T23:59:59+00:00
Accession:  0001448431-26-000007
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OptimizeRx dismisses UHY as auditor, appoints Grant Thornton effective March 2026
--------------------------------------------------------------------------------

- Audit Committee dismissed UHY on March 25, 2026; Grant Thornton appointed March 26, 2026 for FY2026.
- No disagreements or reportable events with UHY, except a previously disclosed material weakness in internal controls.
- Material weakness related to third-party data completeness/accuracy; did not cause restatement or disagreements.
- UHY provided letter agreeing with statements; filed as Exhibit 16.1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1448431/000144843126000007/0001448431-26-000007-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1448431/000144843126000007/oprx-20260324.htm
  HTML page:      https://secwatch.observer/filing/0001448431-26-000007

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer